Lindus Health has introduced its “All-in-One Women’s Health CRO,” a clinical trial service designed specifically for companies developing treatments and diagnostics in women’s health. This new offering aims to address the unique challenges in women’s health research, which requires specialized expertise and a deep understanding of the biological factors affecting women.
The service includes end-to-end clinical trial support, from study initiation to completion, alongside advanced patient recruitment methods such as EHR screening, digital marketing, and partnerships with healthcare providers to speed up enrollment. Lindus Health’s proprietary eClinical platform, Citrus™, provides tools for managing trials, including CTMS, EDC, telehealth, and eConsent, ensuring flexibility throughout the trial process. Additionally, Lindus Health offers regulatory guidance tailored to women’s health and collaborates closely with principal investigators to ensure successful trial execution.
With over 2,500 patients enrolled in women’s health trials across the US, UK, and Europe, Lindus Health’s comprehensive approach supports studies on a wide range of conditions, including pregnancy, ovarian cancer, postpartum depression, and STIs. Lindus Health’s VP of Clinical Operations, Emma Ogburn, emphasizes that women have been underrepresented in clinical research historically, resulting in treatment disparities. She notes that Lindus Health is dedicated to helping sponsors develop effective therapies for women by enrolling diverse, representative study populations that reflect the unique aspects of women’s biology.
Click here to read the original news story.